Orchestra BioMed Holdings, Inc. OBIO
6.01 USD +0.28 (+4.89%)
At closeNov 11, 2026, 4:00 PM EST
6.01 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
5.73 Day range 6.34
3.46 52-week range 6.50
- YTD
- +44.82%
- 1 year
- +46.59%
News
zacks.com Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Misses Revenue Estimates Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.4 per share a year ago.
benzinga.com Orchestra BioMed Hldgs Q3 EPS $(0.30) Beats $(0.40) Estimate, Sales $91.000K Miss $106.000K Estimate Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.40) by 25 percent. This is a 25 percent increase over losses of…
globenewswire.com Orchestra BioMed Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates BACKBEAT Global Pivotal Trial evaluating AVIM Therapy completed enrollment and exceeded enrollment target, with a total of 349 patients randomized. BACKBEAT Trial primary endpoint data planned to be…
globenewswire.com Orchestra BioMed Announces Pricing of Public Offering NEW HOPE, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact…
benzinga.com Orchestra BioMed Commences Common Stock Offering; Terms Not Disclosed Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) ("Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies to patients through strategic collaborations
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers TransMedics Group (NASDAQ:TMDX) stock rose 17.6% to $81.16 during Thursday's after-market session. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Pomdoctor (NASDAQ:POM) shares rose 25.6% to $1.47 during Friday's after-market session. The market value of their outstanding shares is at $8.3 million. GeneDx Holdings (NASDAQ:WGS) shares…